“Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant”, GMSJ, vol. 1, no. S1, Dec. 2025, doi: 10.1349/3143-6587.1.S1.14.